-
公开(公告)号:US20240216329A1
公开(公告)日:2024-07-04
申请号:US18423569
申请日:2024-01-26
申请人: VIVIER CANADA INC.
发明人: Ghislain VIVIER
IPC分类号: A61K31/375 , A61K8/04 , A61K8/41 , A61K8/67 , A61K9/00 , A61K9/06 , A61K47/14 , A61K47/18 , A61K47/22 , A61K47/26 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/42 , A61Q19/08
CPC分类号: A61K31/375 , A61K8/04 , A61K8/41 , A61K8/676 , A61K9/0014 , A61K9/06 , A61K47/14 , A61K47/18 , A61K47/22 , A61K47/26 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/42 , A61Q19/08 , A61K2800/522 , A61K2800/805
摘要: The present invention describes complex topical aqueous compositions for the effective delivery of active ingredients such as putrescine and Vitamin C into the skin. These compositions may be used in a variety of cosmetic and therapeutic applications including for reducing or preventing skin's signs of aging, for promoting wound healing, for reducing or preventing the formation of hypertrophic scar tissue, for reducing or preventing skin irritation and/or inflammation.
-
公开(公告)号:US12023346B1
公开(公告)日:2024-07-02
申请号:US18225244
申请日:2023-07-24
申请人: POVIVA CORP
CPC分类号: A61K31/658 , A61K47/28 , A61K47/36 , A61K47/44 , A61P25/08
摘要: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
-
33.
公开(公告)号:US20240209122A1
公开(公告)日:2024-06-27
申请号:US18553615
申请日:2021-04-01
申请人: Guantian LI
发明人: Guantian LI , Fan ZHU
IPC分类号: C08B31/04 , A23L29/219 , A61K8/73 , A61K47/36
CPC分类号: C08B31/04 , A23L29/219 , A61K8/732 , A61K47/36
摘要: Nonenyl succinic anhydride modified starch and a preparation method therefor, and a Pickering emulsion comprising nonenyl succinic anhydride modified starch. The chemically modified starch, as a particulate emulsifier, has excellent emulsification performance and wide application prospects.
-
公开(公告)号:US12016959B2
公开(公告)日:2024-06-25
申请号:US17163871
申请日:2021-02-01
申请人: OSAKA UNIVERSITY , NATIONAL INSTITUTE FOR MATERIALS SCIENCE , NIPPON ZOKI PHARMACEUTICAL CO., LTD.
IPC分类号: A61K9/70 , A61K31/714 , A61K35/36 , A61K38/18 , A61K45/00 , A61K47/32 , A61K47/34 , A61K47/36 , A61P25/02
CPC分类号: A61K9/7007 , A61K9/70 , A61K31/714 , A61K35/36 , A61K38/18 , A61K38/185 , A61K45/00 , A61K47/32 , A61K47/34 , A61K47/36 , A61P25/02
摘要: A sustained release sheet that includes a drug for treating nerve injury, wherein the sheet is applied to a nerve injury site, can maintain a high concentration of the drug over a long period, and promotes nerve regeneration without stimulating the nerves, even when the sheet is implanted in the periphery of the nerve injury site. Also provided is a production method for the sheet. This sustained drug release sheet for treating nerve injury is a sheet including a non-woven fabric that is formed from nanofibers each containing a drug such as vitamin B12 and a biocompatible polymer such as a biodegradable aliphatic polyester, and is implanted in the periphery of the nerve injury site to promote nerve regeneration.
-
公开(公告)号:US12016867B2
公开(公告)日:2024-06-25
申请号:US17741729
申请日:2022-05-11
发明人: Mahendra G. Shah
IPC分类号: A61K31/573 , A61K9/00 , A61K31/58 , A61K31/661 , A61K45/06 , A61K47/36
CPC分类号: A61K31/573 , A61K9/0019 , A61K31/58 , A61K31/661 , A61K45/06 , A61K47/36 , A61K31/573 , A61K2300/00 , A61K31/661 , A61K2300/00 , A61K31/58 , A61K2300/00
摘要: Disclosed are aqueous pharmaceutical compositions which provide sustained released delivery of corticosteroid compounds. The pharmaceutical composition comprises an insoluble corticosteroid; a soluble corticosteroid; and at least one viscosity enhancing agent. Also provided are methods for using the pharmaceutical compositions in an epidural injection, intra-articular injection, intra-lesional injection, or an intra-ocular injection.
-
36.
公开(公告)号:US20240199660A1
公开(公告)日:2024-06-20
申请号:US18433051
申请日:2024-02-05
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
CPC分类号: C07F9/5728 , A61K9/0053 , A61K9/2054 , A61K47/36 , A61K47/38 , C07D209/16 , C07B2200/13
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
37.
公开(公告)号:US12011504B2
公开(公告)日:2024-06-18
申请号:US18124462
申请日:2023-03-21
发明人: Andrew Favara , Marc Karetny
IPC分类号: A61K9/00 , A61K9/08 , A61K9/16 , A61K9/20 , A61K31/192 , A61K47/12 , A61K47/26 , A61K47/36 , A61K47/44 , A61P29/00
CPC分类号: A61K9/0056 , A61K9/0053 , A61K9/009 , A61K9/08 , A61K9/1623 , A61K9/1652 , A61K9/2013 , A61K9/2018 , A61K9/205 , A61K9/2068 , A61K31/192 , A61K47/12 , A61K47/26 , A61K47/36 , A61K47/44 , A61P29/00
摘要: Disclosed is a dry powder oral formulation that includes an active pharmaceutical ingredient (API), a lecithin powder, a galactomannan, one or more sweetening agents, one or more flavoring agents and an organic acid in a pharmaceutically acceptable preparation. Also disclosed are an excipient composition in absence of an API and methods of making and using the formulations and compositions. Also disclosed is a chewable, swallowable, and/or orally disintegrating tablet comprising an API, a lecithin powder, a galactomannan, one or more sweetening agents, one or more flavoring agents and an organic acid in a pharmaceutically acceptable preparation.
-
公开(公告)号:US20240189265A1
公开(公告)日:2024-06-13
申请号:US18292097
申请日:2022-07-25
发明人: David Friend , Jennifer Kiang , Nicolas J. Pacelli , Mark Walters
IPC分类号: A61K31/196 , A61K9/00 , A61K9/06 , A61K31/5575 , A61K47/10 , A61K47/12 , A61K47/34 , A61K47/36
CPC分类号: A61K31/196 , A61K9/0034 , A61K9/06 , A61K31/5575 , A61K47/10 , A61K47/12 , A61K47/34 , A61K47/36
摘要: The present disclosure generally relates to compositions and techniques for vaginal insertion. In some embodiments, a composition such as a gel may be applied to the vagina of a subject that is relatively viscous, for example, with a viscosity at room temperature of at least 1.5 million cP. The composition may also contain an active ingredient, e.g., dinoprostone, diclofenac, and/or salts thereof. Compositions having such relatively high viscosities may be useful, for example, to prevent the composition from readily exiting the vagina or degrading too quickly. This may, for example, allow the composition to release the active ingredient over a relatively long period of time to the vagina. In some embodiments, such compositions may be prepared by removing air from the composition to increase its viscosity or cause the composition to form a gel, etc. In addition, certain embodiments as described herein are generally directed to techniques for making or using such compositions, kits including such compositions, or the like.
-
公开(公告)号:US20240189227A1
公开(公告)日:2024-06-13
申请号:US18555567
申请日:2022-05-06
IPC分类号: A61K9/00 , A61K31/485 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , A61K47/44 , A61K47/46
CPC分类号: A61K9/0056 , A61K31/485 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , A61K47/44 , A61K47/46
摘要: A composition comprising an edible oil comprising coconut oil, palm kernel oil, palm oil, sunflower oil, hemp seed oil or any combination thereof; an edible triglyceride comprising cocoa butter, mango butter, ghee, hydrogenated palm oil, or any combination thereof; a humectant comprising glycerin, polyethylene glycol, propylene glycol, sorbitol, xylitol, maltitol, or any combination thereof; a binder comprising maltodextrin, sucrose, microcrystalline cellulose, pregelatinized starch, dextrose, lactose, or any combination thereof; and one or more flow aids.
-
公开(公告)号:US11998593B2
公开(公告)日:2024-06-04
申请号:US16877274
申请日:2020-05-18
IPC分类号: A61K39/00 , A61K39/02 , A61K39/12 , A61K39/39 , A61K39/395 , A61K47/34 , A61K47/36 , C07K16/28 , C07K16/30 , C12N7/00
CPC分类号: A61K39/0011 , A61K39/001102 , A61K39/001156 , A61K39/001157 , A61K39/00117 , A61K39/001171 , A61K39/00118 , A61K39/001182 , A61K39/001186 , A61K39/001191 , A61K39/001192 , A61K39/02 , A61K39/12 , A61K39/39 , A61K39/3955 , A61K47/34 , A61K47/36 , C07K16/2803 , C07K16/2818 , C07K16/30 , C07K16/3053 , C12N7/00 , A61K2039/507 , A61K2039/5152 , A61K2039/54 , A61K2039/55516 , A61K2039/55522 , A61K2039/55561 , C07K2317/21 , C07K2317/24
摘要: The present invention comprises compositions, methods, and devices for enhancing an endogenous immune response against a cancer. Devices and methods provide therapeutic immunity to subjects against cancer.
-
-
-
-
-
-
-
-
-